Clinical Trial Update: International PMS Study - KOGENATE Bayer

View source ↗

Summary

Clinical trial update for KOGENATE Bayer indicates the International PMS Study has completed in Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• KOGENATE Bayer (antihemophilic factor (recombinant))

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: COMPLETED